Your browser doesn't support javascript.
loading
Resveratrol does not benefit patients with nonalcoholic fatty liver disease.
Chachay, Veronique S; Macdonald, Graeme A; Martin, Jennifer H; Whitehead, Jonathan P; O'Moore-Sullivan, Trisha M; Lee, Paul; Franklin, Michael; Klein, Kerenaftali; Taylor, Paul J; Ferguson, Maree; Coombes, Jeff S; Thomas, Gethin P; Cowin, Gary J; Kirkpatrick, Carl M J; Prins, Johannes B; Hickman, Ingrid J.
Afiliação
  • Chachay VS; University of Queensland Diamantina Institute, University of Queensland, Translational Research Institute, Brisbane, Australia; Department of Nutrition and Dietetics, Princess Alexandra Hospital, Brisbane, Australia. Electronic address: v.chachay@uq.edu.au.
  • Macdonald GA; School of Medicine Metro-South, University of Queensland, Brisbane, Australia; Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Brisbane, Australia.
  • Martin JH; School of Medicine Metro-South, University of Queensland, Brisbane, Australia.
  • Whitehead JP; Mater Medical Research Institute, Brisbane, Australia.
  • O'Moore-Sullivan TM; School of Medicine Metro-South, University of Queensland, Brisbane, Australia; Department of Endocrinology, Princess Alexandra Hospital, Brisbane, Australia.
  • Lee P; School of Medicine Metro-South, University of Queensland, Brisbane, Australia; Department of Endocrinology, Princess Alexandra Hospital, Brisbane, Australia.
  • Franklin M; Department of Clinical Pharmacology, Princess Alexandra Hospital, Brisbane, Australia.
  • Klein K; Queensland Clinical Trials and Biostatistics Centre, University of Queensland, Brisbane, Australia.
  • Taylor PJ; Department of Clinical Pharmacology, Princess Alexandra Hospital, Brisbane, Australia.
  • Ferguson M; Department of Nutrition and Dietetics, Princess Alexandra Hospital, Brisbane, Australia; School of Human Movement Studies, University of Queensland, Brisbane, Australia.
  • Coombes JS; School of Human Movement Studies, University of Queensland, Brisbane, Australia.
  • Thomas GP; University of Queensland Diamantina Institute, University of Queensland, Translational Research Institute, Brisbane, Australia.
  • Cowin GJ; Centre for Advanced Imaging, University of Queensland, Brisbane, Australia.
  • Kirkpatrick CM; Centre for Medicine Use and Safety, Monash University, Melbourne, Australia.
  • Prins JB; University of Queensland Diamantina Institute, University of Queensland, Translational Research Institute, Brisbane, Australia; Mater Medical Research Institute, Brisbane, Australia.
  • Hickman IJ; University of Queensland Diamantina Institute, University of Queensland, Translational Research Institute, Brisbane, Australia; Department of Nutrition and Dietetics, Princess Alexandra Hospital, Brisbane, Australia; Mater Medical Research Institute, Brisbane, Australia.
Clin Gastroenterol Hepatol ; 12(12): 2092-103.e1-6, 2014 Dec.
Article em En | MEDLINE | ID: mdl-24582567
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estilbenos / Fármacos Gastrointestinais / Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Clinical_trials Limite: Adult / Aged / Humans / Male / Middle aged País/Região como assunto: Oceania Idioma: En Revista: Clin Gastroenterol Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estilbenos / Fármacos Gastrointestinais / Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Clinical_trials Limite: Adult / Aged / Humans / Male / Middle aged País/Região como assunto: Oceania Idioma: En Revista: Clin Gastroenterol Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2014 Tipo de documento: Article